The Science Behind OneTest for Longevity™

OneTest for Longevity™ represents a paradigm shift in preventive health assessment, combining established biomarker analysis with validated dietary evaluation tools to provide a comprehensive picture of inflammatory status and its relationship to healthy aging. Our approach is grounded in decades of peer-reviewed research demonstrating the central role of chronic inflammation in age-related disease development.

Chronic low-level inflammation is a persistent mild activation of the immune system that continues overtime without obvious symptoms or acute infection. Although subtle, this ongoing inflammatory state gradually damages tissues and is strongly linked to cardiovascular disease, diabetes, liver disease, and accelerated aging. A substantial body of scientific evidence shows that targeted dietary and lifestyle interventions can significantly reduce inflammatory biomarkers within weeks—providing a meaningful pathway to improved healthspan and longevity.

The Synergistic Approach

OneTest for Longevity™ employs a unique dual-track assessment methodology that addresses the limitations of single-parameter testing:

Track 1: Internal Biomarker Assessment

  • Direct measurement of inflammatory biomarkers in blood
  • Provides snapshot of current physiological inflammatory state
  • Includes markers with established associations to chronic disease risk

Track 2: Dietary Inflammatory Assessment

  • Utilizes the validated Dietary Inflammatory Index (DII™)
  • Captures dietary patterns affecting inflammation
  • Compensates for acute fluctuations in biomarker levels

This combined approach enhances predictive power for chronic disease risk beyond either method alone, as DII reflects upstream behavioral patterns while laboratory values demonstrate downstream physiological effects

The Dietary Inflammatory Index (DII™): Two Decades of Validation

Development and Scientific Foundation

The Dietary Inflammatory Index was developed and refined over 20 years at the University of South Carolina, based on comprehensive analysis of how specific foods influence inflammatory biomarkers. The development process involved:

  • Analysis of thousands of peer-reviewed publications
  • Validation studies across multiple populations
  • Assessment of 45 dietary components including macronutrients, vitamins, minerals, and bioactive compounds
  • Correlation with inflammatory biomarkers including those measured in OneTest for Longevity™

Global Validation and Research Impact

The DII has demonstrated unprecedented scientific validation:

  • 1,000+ studies utilizing the DII across 500+ research groups
  • Research conducted in >90 countries worldwide
  • 1,400+ peer-reviewed publications validating its applications
  • Consistent associations with inflammatory biomarkers across diverse populations

DII Scoring and Interpretation

The DII generates scores ranging from -10 (maximally anti-inflammatory) to +10 (maximally pro-inflammatory), with most individuals scoring between -7 and +7. Lower (negative) scores indicate diets that reduce inflammatory burden, while higher (positive) scores suggest diets that promote chronic inflammation.

Clinical Evidence for DII Predictive Power

Cardiovascular Disease Risk

A large prospective study published in Nutrition Journal demonstrated that men with high DII scores had a 50% higher risk of first myocardial infarction, even after adjusting for traditional laboratory-based risk factors. Additional research in patients undergoing coronary artery bypass grafting showed that higher DII scores were associated with:

  • Elevated triglycerides
  • Increased high-sensitivity C-reactive protein (hs-CRP)
  • Lower HDL cholesterol levels
  • Higher surgical risk scores

Biomarker Science: Measuring Inflammatory Status

Biomarker

Overall functional significance

Pattern in chronic low‑grade inflammation

Biological link to inflammation

Key clinical relevance for low‑grade inflammation

Other major disease associations

Albumin

Maintains oncotic pressure; carrier protein; antioxidant capacity

Low‑normal or mildly low

Negative acute‑phase reactant; hepatic synthesis suppressed by inflammatory cytokines

Lower levels track with chronic disease burden, frailty, and poor long‑term outcomes

Liver disease, nephrotic syndrome, malnutrition, chronic illness

ALP

Enzyme of bile ducts and osteoblasts; marker of biliary and bone activity

Mild elevation when liver/bone involved in chronic inflammation

Reflects cholestasis or bone turnover, which can be driven by inflammatory processes

Non‑specific; supports context of hepatobiliary or bone inflammation

Cholestasis, bone disease, hyperparathyroidism, malignancy

ApoA‑I

Major HDL protein; anti‑inflammatory, antioxidant, promotes cholesterol efflux

Tends to decrease

Negative acute‑phase reactant; reduced HDL quantity and function in inflammatory states

Low ApoA‑I indicates impaired reverse cholesterol transport and higher cardiometabolic risk

Autoimmune disease, chronic infection, dyslipidemia

ApoB

Structural protein of LDL/VLDL; central to atherogenesis

Tends to increase (more atherogenic particles)

Inflammation and insulin resistance increase VLDL/LDL particle production

High ApoB = high atherogenic particle number; strong marker of inflammation‑driven ASCVD

Familial hyperlipidemia, NAFLD, diabetes, metabolic syndrome

CRP (hs‑CRP)

Opsonin; innate immune mediator; global inflammation barometer

1–3 mg/L = mild; >3 mg/L = elevated chronic inflammation

Classic positive acute‑phase reactant driven by IL‑6 and other cytokines

Integrates multiple inflammatory inputs; strong predictor of cardiometabolic risk

Infection, autoimmune disease, malignancy

LDL‑C

Cholesterol delivery to tissues; becomes pathogenic when modified/retained in vessel wall

Often normal–high; more small dense and oxidized LDL in inflammation

Oxidative and glycation changes under inflammatory stress increase LDL atherogenicity

Elevated LDL‑C, especially with high CRP/ApoB, signals inflammation‑driven atherosclerosis

Hypothyroidism, nephrotic syndrome, familial hypercholesterolemia

Triglycerides

Energy transport/storage; sensitive marker of metabolic health

Frequently elevated

TNF‑α/IL‑6 and insulin resistance increase hepatic VLDL output and reduce clearance

High TGs are a hallmark of metabolic inflammation and insulin resistance

NAFLD, diabetes, pancreatitis (very high), obesity

TSH

Master regulator of thyroid hormone production and systemic metabolic rate

Mild upward shift possible in chronic/metabolic inflammation

Cytokines alter hypothalamic–pituitary–thyroid axis and peripheral T4→T3 conversion

Borderline high TSH may coexist with obesity/metabolic inflammation, but is non‑specific

Hypothyroidism, autoimmune thyroiditis, pituitary disease

Uric acid

Circulating antioxidant but intracellular pro‑oxidant; purine metabolism end‑product

High‑normal or elevated

Uric acid activates NLRP3 inflammasome; associated with oxidative stress and endothelial dysfunction

Elevated urate tracks with metabolic syndrome, HTN, CKD, cardiometabolic risk

Gout, nephrolithiasis, CKD

Vitamin B12

Cofactor for DNA synthesis and methylation; essential for neurologic function

Can be normal or high in chronic disease

Inflammation alters transport proteins (transcobalamin, haptocorrin) and hepatic release

High B12 without supplementation can be a flag for chronic inflammatory or liver disease

Pernicious anemia, malabsorption, liver disease, myeloproliferative states

Vitamin D

Regulates calcium–bone axis and immune tone; broad immunomodulatory and anti‑inflammatory roles

Often low (<20–30 ng/mL)

Modulates innate/adaptive immunity; deficiency favors pro‑inflammatory cytokine milieu

Low vitamin D is consistently associated with chronic low‑grade inflammatory conditions

Osteoporosis, CKD, malabsorption, autoimmune disease

Evidence Base: Inflammation and Chronic Disease

Cardiovascular Disease

The relationship between inflammation and cardiovascular disease is well-established through multiple pathways:

  • Inflammatory markers predict cardiovascular events independent of traditional risk factors
  • C-reactive protein serves as both marker and mediator of atherosclerosis
  • Anti-inflammatory dietary patterns demonstrate cardioprotective effects
  • Lipid-associated inflammation contributes to plaque instability

Type II Diabetes

Chronic inflammation creates a microenvironment conducive to development of Type II Diabetes through:

  • Insulin resistance: Cytokines activate key molecular pathways in liver, muscle, and adipose tissue, impairing insulin signaling and glucose uptake
  • Adipose tissue: Overnutrition and obesity recuit macrophages and other immunce cells into adipose tissue, creating a chronic low-grade inflammatory milieu that promotes systemic insulin resistance
  • β-cell stress and failure: Chronic exposure to inflammatory mediators and metabolic stress contributes to β-cell dysfunction and loss

Liver Disease

Chronic low-grade inflammation is a defining feature of metabolic syndrome, and NAFLD/MASLD are essentially the hepatic manifestation of system metabolic inflammation.

  • Inflammatory cytokines impair mitochondrial function, increase oxidative stress, and promote apoptosis in the liver.
  • Liver macrophages respond to systemic inflammatory signals driving hepatic injury and stellate cell activation.
  • Chronic inflammatory signaling activates hepatic stellate cells, leading to progressive fibrosis and cirrhosis.
  • Insulin resistance in liver and adipose tissue due to chronic inflammation promote steatosis.

Thyroid Function

Subclinical hypothyroidism often results from low-grade systemic inflammation. Thyroiditis is an overt form of inflammation.

  • Inflammatory cytokines can alter thyroid hormone secretion contributing to subclinical hypothyroidism.
  • Chronic immune activation can promote loss of tolerance to thyroid antigens leading to thyroiditis.
  • Obesity and metabolic inflammation promote inflammatory signaling in adipose tissue feeding back on thyroid hormone metabolism.

Clinical Applications and Monitoring

Quarterly Assessment Protocol

OneTest for Longevity™ is designed for regular monitoring to track inflammatory status changes over time. The quarterly assessment protocol allows for:

  • Detection of dietary intervention effects within 3-month periods
  • Adjustment of lifestyle recommendations based on biomarker trends
  • Long-term tracking of inflammatory burden and chronic disease risk
  • Personalized optimization of anti-inflammatory strategies

Integration with Healthcare

The comprehensive reporting provided by OneTest for Longevity™ facilitates integration with existing healthcare:

  • Results formatted for easy sharing with healthcare providers
  • Established reference ranges for clinical interpretation
  • Evidence-based recommendations for lifestyle modifications
  • Support for preventive medicine approaches

Scientific Advisory and Development

OneTest for Longevity™ benefits from collaboration with leading researchers in the field of diet and inflammation, including Dr. James Hébert, the primary developer of the Dietary Inflammatory Index and author of more peer-reviewed publications on diet and inflammation than any researcher worldwide. This scientific foundation ensures that our assessments and recommendations remain current with the latest research developments.

References: 

  1. Shivappa N, Steck SE, Hurley TG, Hussey JR, Hébert JR. Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr. 2014;17(8):1689-1696. doi:10.1017/S1368980013002115
  2. Hébert JR, Shivappa N, Wirth MD, Hussey JR, Hurley TG. Perspective: The Dietary Inflammatory Index (DII)-Lessons Learned, Improvements Made, and Future Directions. Adv Nutr. 2019;10(2):185-195. doi:10.1093/ADVANCES/NMY071
  3. Healthy Eating Index (HEI) | Food and Nutrition Service. Accessed June 4, 2025. https://www.fns.usda.gov/cnpp/healthy-eating-index-hei
  4. Vahid F, Bohn T, Chiriboga D, Hébert JR. Diet, inflammation, and cardiovascular disease. Diet, Inflammation, Heal. Published online January 1, 2022:367-472. doi:10.1016/B978-0-12-822130-3.00015-6
  5. Wenzl FA, Ambrosini S, Mohammed SA, et al. Inflammation in metabolic cardiomyopathy. Front Cardiovasc Med. 2021;8:742178. doi:10.3389/FCVM.2021.742178/BIBTEX
  6. Chumanevich AA, Spicer M, Hofseth LJ, Hébert JR. Diet, inflammation, and cancer. In: Hebert J, Hofseth L, eds. Diet, Inflammation, and Health. 1st ed. Academic Press; 2022:473-529. doi:10.1016/B978-0-12-822130-3.00016-8
  7. Lécuyer L, Laouali N, Viallon V, et al. Associations between dietary inflammatory scores and biomarkers of inflammation in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Clin Nutr. 2023;42(7):1115-1125. doi:10.1016/J.CLNU.2023.05.012
  8. Skoczek-Rubińska A, Muzsik-Kazimierska A, Chmurzynska A, Jamka M, Walkowiak J, Bajerska J. Inflammatory Potential of Diet Is Associated with Biomarkers Levels of Inflammation and Cognitive Function among Postmenopausal Women. Nutrients. 2021;13(7). doi:10.3390/NU13072323
  9. Shakya PR, Melaku YA, Shivappa N, et al. Dietary inflammatory index (DII®) and the risk of depression symptoms in adults. Clin Nutr. 2021;40(5):3631-3642. doi:10.1016/J.CLNU.2020.12.031
  10. Saul AM, Taylor B V., Blizzard L, et al. A pro-inflammatory diet in people with multiple sclerosis is associated with an increased rate of relapse and increased FLAIR lesion volume on MRI in early multiple sclerosis: A prospective cohort study. Mult Scler. 2023;29(8):1012-1023. doi:10.1177/13524585231167739
  11. Hébert JR, Hofseth LJ. Diet, Inflammation, and Health. 1st ed. Academic Press; 2022. doi:10.1016/C2019-0-04033-2
  12. Hébert JR, Hurley TG, Steck SE, et al. Considering the Value of Dietary Assessment Data in Informing Nutrition-Related Health Policy. Adv Nutr. 2014;5(4):447. doi:10.3945/AN.114.006189
  13. Marx W, Veronese N, Kelly JT, et al. The Dietary Inflammatory Index and Human Health: An Umbrella Review of Meta-Analyses of Observational Studies. Adv Nutr. 2021;12(5):1681-1690. doi:10.1093/ADVANCES/NMAB037
  14. Phillips CM, Chen LW, Heude B, et al. Dietary Inflammatory Index and Non-Communicable Disease Risk: A Narrative Review. Nutrients. 2019;11(8). doi:10.3390/NU11081873
  15. Ohlson MA. Diet therapy in the U.S. in the past 200 years. A Bicentennial study. J Am Diet Assoc. 1976;69(5):490-497.
  16. Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol. 2005;23(24):5814-5830. doi:10.1200/JCO.2005.01.230
  17. Prentice RL, Anderson GL. The women’s health initiative: lessons learned. Annu Rev Public Health. 2008;29:131-150. doi:10.1146/ANNUREV.PUBLHEALTH.29.020907.090947
  18. Goldberg JP, Sliwa SA. Communicating actionable nutrition messages: challenges and opportunities. Proc Nutr Soc. 2011;70(1):26-37. doi:10.1017/S0029665110004714
  19. Walker TB, Parker MJ. Lessons from the war on dietary fat. J Am Coll Nutr. 2014;33(4):347-351. doi:10.1080/07315724.2013.870055
  20. Micha R, Coates J, Leclercq C, Charrondiere UR, Mozaffarian D. Global Dietary Surveillance: Data Gaps and Challenges. https://doi.org/101177/0379572117752986. 2018;39(2):175-205. doi:10.1177/0379572117752986
  21. Fowler ME, Akinyemiju TF. Meta-analysis of the association between dietary inflammatory index (DII) and cancer outcomes. Int J Cancer. 2017;141(11):2215-2227. doi:10.1002/IJC.30922,
  22. Zhu M, Ma Z, Zhang X, et al. C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and Mendelian randomization analysis. BMC Med. 2022;20(1):1-13. doi:10.1186/S12916-022-02506-X/FIGURES/3
  23. Georgila K, Vyrla D, Drakos E. Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer. Cancers 2019, Vol 11, Page 1097. 2019;11(8):1097. doi:10.3390/CANCERS11081097
  24. Bielecka-Dąbrowa A, Hannam S, Rysz J, Banach M. Malignancy-Associated Dyslipidemia. Open Cardiovasc Med J. 2011;5(1):35. doi:10.2174/1874192401105010035
  25. Long J, Zhang C-J, Zhu N, et al. Lipid metabolism and carcinogenesis, cancer development. Am J Cancer Res. 2018;8(5):778.
  26. LDL cholesterol: How low can you (safely) go? – Harvard Health. Accessed May 30, 2025. https://www.health.harvard.edu/blog/ldl-cholesterol-how-low-can-you-safely-go-2020012018638
  27. Lower Your LDL | American Heart Association. Accessed May 30, 2025. https://www.heart.org/en/health-topics/cholesterol/hdl-good-ldl-bad-cholesterol-and-triglycerides/lower-your-ldl
  28. C-Reactive Protein test to screen for heart disease: Why do we need another test? – Harvard Health. Accessed May 30, 2025. https://www.health.harvard.edu/heart-health/c-reactive-protein-test-to-screen-for-heart-disease
  29. Engelhart MJ, Geerlings MI, Meijer J, et al. Inflammatory Proteins in Plasma and the Risk of Dementia: The Rotterdam Study. Arch Neurol. 2004;61(5):668-672. doi:10.1001/ARCHNEUR.61.5.668
  30. Lee M, Lee KJ, Kim J, et al. Low-density lipoprotein cholesterol levels and risk of incident dementia: a distributed network analysis using common data models. J Neurol Neurosurg Psychiatry. Published online April 1, 2025. doi:10.1136/JNNP-2024-334708
  31. Dimache AM, Șalaru DL, Sascău R, Stătescu C. The Role of High Triglycerides Level in Predicting Cognitive Impairment: A Review of Current Evidence. Nutrients. 2021;13(6):2118. doi:10.3390/NU13062118
  32. Min M, Tarmaster A, Bodemer A, Sivamani RK. The Influence of a Plant-Based Diet on Skin Health: Inflammatory Skin Diseases, Skin Healing, and Plant-Based Sources of Micro- and Macro-Nutrients. Life 2024, Vol 14, Page 1439. 2024;14(11):1439. doi:10.3390/LIFE14111439
  33. Molla A. Dietary Patterns and their Impact on Atopic Dermatitis: A Comprehensive Review. Open Dermatol J. 2024;18(1). doi:10.2174/0118743722306189240520075943,
  34. Tomas M, Günal-Köroğlu D, Kamiloglu S, Ozdal T, Capanoglu E. The state of the art in anti-aging: plant-based phytochemicals for skin care. Immun Ageing 2025 221. 2025;22(1):1-23. doi:10.1186/S12979-025-00498-9
  35. Watzl B, Kulling SE, Möseneder J, Barth SW, Bub A. A 4-wk intervention with high intake of carotenoid-rich vegetables and fruit reduces plasma C-reactive protein in healthy, nonsmoking men. 2005;82(5):1052-1058.
  36. Eichelmann F, Schwingshackl L, Fedirko V, Aleksandrova K. Effect of plant-based diets on obesity-related inflammatory profiles: a systematic review and meta-analysis of intervention trials. Obes Rev. 2016;17(11):1067-1079. doi:10.1111/OBR.12439,
  37. Sutliffe JT, Wilson LD, de Heer HD, Foster RL, Carnot MJ. C-reactive protein response to a vegan lifestyle intervention. Complement Ther Med. 2015;23(1):32-37.
  38. Macknin M, Kong T, Weier A, et al. Plant-based, no-added-fat or American heart association diets: Impact on cardiovascular risk in obese children with hypercholesterolemia and their parents. J Pediatr. 2015;166(4):953-959.e3. doi:10.1016/j.jpeds.2014.12.058
  39. Menzel J, Jabakhanji A, Biemann R, Mai K, Abraham K, Weikert C. Systematic review and meta-analysis of the associations of vegan and vegetarian diets with inflammatory biomarkers. Sci Rep. 2020;10(1). doi:10.1038/S41598-020-78426-8,
  40. Meydani SN, Das SK, Pieper CF, et al. Long-term moderate calorie restriction inhibits inflammation without impairing cell-mediated immunity: A randomized controlled trial in non-obese humans. Aging (Albany NY). 2016;8(7):1416-1431. doi:10.18632/AGING.100994,
  41. Shah B, Newman JD, Woolf K, et al. Anti-inflammatory effects of a vegan diet versus the american heart association–recommended diet in coronary artery disease trial. J Am Heart Assoc. 2018;7(23). doi:10.1161/JAHA.118.011367,
  42. Schultz H, Ying GS, Dunaief JL, Dunaief DM. Rising Plasma Beta-Carotene Is Associated With Diminishing C-Reactive Protein in Patients Consuming a Dark Green Leafy Vegetable–Rich, Low Inflammatory Foods Everyday (LIFE) Diet. Am J Lifestyle Med. 2021;15(6):634-643. doi:10.1177/1559827619894954,
  43. Kelley DS, Rasooly R, Jacob RA, Kader AA, Mackey BE. Consumption of bing sweet cherries lowers circulating concentrations of inflammation markers in healthy men and women. J Nutr. 2006;136(4):981-986. doi:10.1093/jn/136.4.981
  44. Chai SC, Hooshmand S, Saadat RL, Payton ME, Brummel-Smith K, Arjmandi BH. Daily Apple versus Dried Plum: Impact on Cardiovascular Disease Risk Factors in Postmenopausal Women. J Acad Nutr Diet. 2012;112(8):1158-1168. doi:10.1016/j.jand.2012.05.005
  45. Moazen S, Amani R, Homayouni Rad A, Shahbazian H, Ahmadi K, Taha Jalali M. Effects of freeze-dried strawberry supplementation on metabolic biomarkers of atherosclerosis in subjects with type 2 diabetes: A randomized double-blind controlled trial. Ann Nutr Metab. 2013;63(3):256-264. doi:10.1159/000356053,
  46. Nair AR, Mariappan N, Stull AJ, Francis J. Blueberry supplementation attenuates oxidative stress within monocytes and modulates immune cell levels in adults with metabolic syndrome: A randomized, double-blind, placebo-controlled trial. Food Funct. 2017;8(11):4118-4128. doi:10.1039/C7FO00815E,
  47. Wang P, Zhang Q, Hou H, et al. The effects of pomegranate supplementation on biomarkers of inflammation and endothelial dysfunction: A meta-analysis and systematic review. Complement Ther Med. 2020;49. doi:10.1016/j.ctim.2020.102358
  48. López-Chillón MT, Carazo-Díaz C, Prieto-Merino D, Zafrilla P, Moreno DA, Villaño D. Effects of long-term consumption of broccoli sprouts on inflammatory markers in overweight subjects. Clin Nutr. 2019;38(2):745-752. doi:10.1016/j.clnu.2018.03.006
  49. Ghavipour M, Saedisomeolia A, Djalali M, et al. Tomato juice consumption reduces systemic inflammation in overweight and obese females. Br J Nutr. 2013;109(11):2031-2035. doi:10.1017/S0007114512004278,
  50. Dai X, Stanilka JM, Rowe CA, et al. Consuming Lentinula edodes (Shiitake) Mushrooms Daily Improves Human Immunity: A Randomized Dietary Intervention in Healthy Young Adults. J Am Coll Nutr. 2015;34(6):478-487. doi:10.1080/07315724.2014.950391,
  51. Vallianou N, Tsang C, Taghizadeh M, Davoodvandi A, Jafarnejad S. Effect of cinnamon (Cinnamomum Zeylanicum) supplementation on serum C-reactive protein concentrations: A meta-analysis and systematic review. Complement Ther Med. 2019;42:271-278. doi:10.1016/j.ctim.2018.12.005
  52. Moosavian SP, Paknahad Z, Habibagahi Z, Maracy M. The effects of garlic (Allium sativum) supplementation on inflammatory biomarkers, fatigue, and clinical symptoms in patients with active rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial. Phyther Res. 2020;34(11):2953-2962. doi:10.1002/PTR.6723,
  53. Morvaridzadeh M, Fazelian S, Agah S, et al. Effect of ginger (Zingiber officinale) on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials. Cytokine. 2020;135. doi:10.1016/j.cyto.2020.155224
  54. Lefevre M, Jonnalagadda S. Effect of whole grains on markers of subclinical inflammation. 2012;70(7):387-396. doi:10.1111/J.1753-4887.2012.00487.X
  55. Vitaglione P, Mennella I, Ferracane R, et al. Whole-grain wheat consumption reduces inflammation in a randomized controlled trial on overweight and obese subjects with unhealthy dietary and lifestyle behaviors: Role of polyphenols bound to cereal dietary fiber. Am J Clin Nutr. 2015;101(2):251-261. doi:10.3945/ajcn.114.088120
  56. Hosseinpour-Niazi S, Mirmiran P, Fallah-Ghohroudi A, Azizi F. Non-soya legume-based therapeutic lifestyle change diet reduces inflammatory status in diabetic patients: A randomised cross-over clinical trial. Br J Nutr. 2015;114(2):213-219. doi:10.1017/S0007114515001725,
  57. Bahorun T, Luximon-Ramma A, Gunness TK, et al. Black tea reduces uric acid and C-reactive protein levels in humans susceptible to cardiovascular diseases. Toxicology. 2010;278(1):68-74. doi:10.1016/J.TOX.2009.11.024
  58. Yu Z, Malik VS, Keum NN, et al. Associations between nut consumption and inflammatory biomarkers. Am J Clin Nutr. 2016;104(3):722. doi:10.3945/AJCN.116.134205
  59. Zivkovic AM, Telis N, German JB, Hammock BD. Dietary omega-3 fatty acids aid in the modulation of inflammation and metabolic health. Calif Agric. 2011;65(3):106. doi:10.3733/CA.V065N03P106
  60. Bautmans I, Salimans L, Njemini R, Beyer I, Lieten S, Liberman K. The effects of exercise interventions on the inflammatory profile of older adults: A systematic review of the recent literature. Exp Gerontol. 2021;146:111236. doi:10.1016/J.EXGER.2021.111236
  61. Wang YH, Tan J, Zhou HH, Cao M, Zou Y. Long-term exercise training and inflammatory biomarkers in healthy subjects: a meta-analysis of randomized controlled trials. Front Psychol. 2023;14:1253329. doi:10.3389/FPSYG.2023.1253329/BIBTEX
  62. Ferrer MD, Capó X, Martorell M, et al. Regular Practice of Moderate Physical Activity by Older Adults Ameliorates Their Anti-Inflammatory Status. Nutr 2018, Vol 10, Page 1780. 2018;10(11):1780. doi:10.3390/NU10111780
  63. Ye L, Mauro TM, Dang E, et al. Topical applications of an emollient reduce circulating pro-inflammatory cytokine levels in chronically aged humans: a pilot clinical study. J Eur Acad Dermatology Venereol. 2019;33(11):2197-2201. doi:10.1111/JDV.15540,
  64. Zhang B, Lai RC, Sim WK, Choo ABH, Lane EB, Lim SK. Topical Application of Mesenchymal Stem Cell Exosomes Alleviates the Imiquimod Induced Psoriasis-Like Inflammation. Int J Mol Sci 2021, Vol 22, Page 720. 2021;22(2):720. doi:10.3390/IJMS22020720
  65. 8 Best Anti-Inflammatory Ingredients for Skin. Accessed June 4, 2025. https://www.realsimple.com/beauty-fashion/skincare/skin-inflammation